Stock

Jefferies upgrades Ecolab to ‘buy’ on growth potential, stronger margins

Investing.com — Jefferies has upgraded Ecolab’s (NYSE:ECL) rating to “buy” from “hold,” reflecting improved expectations for the company’s performance over the coming years. 

The analysts at Jefferies argue that Ecolab’s business model is evolving in ways that make it more competitive and resilient, driven by a better product mix, digitalization efforts, and a shift towards value-added services.

As per the analysts Ecolab’s shift from traditional chemical services to solutions that leverage scale, sensor networks, and analytics positions it to capitalize on long-term efficiency gains. 

These changes are expected to boost the company’s earnings potential, with Jefferies projecting an annual EPS growth rate of about 15% through 2026. This forecast surpasses the broader market consensus, which anticipates EPS growth closer to 11%.

Jefferies mentions that while Ecolab is not immune to macroeconomic challenges, such as fluctuations in demand from restaurants and hotels, the company’s ability to integrate Internet of Things solutions and adopt a more sustainable business model is likely to mitigate risks. 

With the COVID-era disruptions easing, Ecolab is seen to be accelerating its transition towards digital platforms, which could drive significant margin expansion.

The analysts further argue that Ecolab’s valuation is well-supported, especially in a market that anticipates falling interest rates and ongoing stimulus measures. 

Jefferies suggests that Ecolab’s competitive strengths—including its core chemistry expertise, operational culture, and economies of scale—position the company favorably relative to peers. 

The analysts note that if the company can maintain consistent margin growth, it is likely to outperform, with an estimated 19% upside potential in share price over the next 12 months.

The note flags that there are still challenges, particularly around financial leverage and end-market volatility. 

For example, capital allocation decisions, especially in areas like healthcare, will need to be carefully managed to avoid dragging on profitability. 

Yet, Jefferies believes the company’s proactive approach to cost control and pricing strategies should offset most of these headwinds.

This post appeared first on investing.com

You May Also Like

Editor's Pick

Former president Donald Trump and his allies have filed hundreds of lawsuits, with more to come, seeking to tighten voting rules or disqualify voters....

Economy

LONDON (Reuters) – Bank of England interest rate-setter Megan Greene said she still believed the central bank should take a cautious approach to cutting...

Editor's Pick

Sister Stephanie Schmidt had a hunch about what her fellow nuns would discuss over dinner at their Erie, Pennsylvania, monastery on Wednesday night. The...

Latest News

Warner Bros. Discovery said Thursday its streaming platform Max added 7.2 million global subscribers in the third quarter. It marked the biggest quarterly growth for...

Disclaimer: beneficialinvestmentnow.com, its managers, its employees, and assigns (collectively “The Company”) do not make any guarantee or warranty about what is advertised above. Information provided by this website is for research purposes only and should not be considered as personalized financial advice. The Company is not affiliated with, nor does it receive compensation from, any specific security. The Company is not registered or licensed by any governing body in any jurisdiction to give investing advice or provide investment recommendation. Any investments recommended here should be taken into consideration only after consulting with your investment advisor and after reviewing the prospectus or financial statements of the company.

Copyright © 2024 beneficialinvestmentnow.com

Exit mobile version